What is ATL?
ATL, formerly Ad Tape & Label Co, operates a modern manufacturing facility in Menomonee Falls, Wisconsin. The company excels in producing anti-counterfeiting security labels, multi-panel booklet labels, custom die-cut components, disposable medical devices, direct mail, and product labels. ATL's stringent adherence to FDA cGMP compliance, validated by numerous audits from top pharmaceutical firms, underscores its reputation for quality. Their Quality Management System (QMS) is built upon ISO 9000, QS-9000, ISO 13485, and 21 CFR 210, 211, and 820 standards, with EN 46002 compliance for exports, ensuring robust production of standard labels, medical devices, and complex pharmaceutical multi-page booklets.
How much funding has ATL raised?
ATL has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in ATL
PPP
Public-Private Partnership
What's next for ATL?
The recent strategic investment, alongside the company's substantial total funding, indicates a strong trajectory for ATL. This backing is likely to fuel advancements in their anti-counterfeiting technologies and expand their capacity for high-compliance pharmaceutical and medical device manufacturing. ATL is poised to further solidify its market leadership by leveraging this capital for operational enhancements and potentially exploring new market segments that demand their specialized labeling and device solutions.
See full ATL company page
